Kornitzer Capital Management Inc. KS decreased its position in Agilent Technologies Inc (NYSE:A) by 5.4% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 267,803 shares of the medical research company’s stock after selling 15,322 shares during the period. Kornitzer Capital Management Inc. KS’s holdings in Agilent Technologies were worth $19,997,000 as of its most recent SEC filing.
A number of other institutional investors have also recently bought and sold shares of A. American Century Companies Inc. raised its holdings in Agilent Technologies by 20.6% during the 1st quarter. American Century Companies Inc. now owns 4,928,415 shares of the medical research company’s stock valued at $396,146,000 after acquiring an additional 840,850 shares during the period. Investec Asset Management LTD raised its holdings in Agilent Technologies by 447.2% during the 2nd quarter. Investec Asset Management LTD now owns 648,507 shares of the medical research company’s stock valued at $14,350,000 after acquiring an additional 529,993 shares during the period. Cantillon Capital Management LLC raised its holdings in Agilent Technologies by 11.5% during the 2nd quarter. Cantillon Capital Management LLC now owns 3,945,223 shares of the medical research company’s stock valued at $294,589,000 after acquiring an additional 405,598 shares during the period. Royal London Asset Management Ltd. increased its holdings in shares of Agilent Technologies by 107.3% in the first quarter. Royal London Asset Management Ltd. now owns 739,842 shares of the medical research company’s stock worth $59,498,000 after purchasing an additional 382,902 shares during the period. Finally, MERIAN GLOBAL INVESTORS UK Ltd increased its holdings in shares of Agilent Technologies by 6,833.0% in the first quarter. MERIAN GLOBAL INVESTORS UK Ltd now owns 379,583 shares of the medical research company’s stock worth $30,510,000 after purchasing an additional 374,108 shares during the period.
Several research firms have recently weighed in on A. Wolfe Research began coverage on shares of Agilent Technologies in a report on Thursday, May 30th. They issued a “peer perform” rating on the stock. Zacks Investment Research cut shares of Agilent Technologies from a “hold” rating to a “sell” rating and set a $71.00 price target on the stock. in a report on Tuesday, July 16th. Piper Jaffray Companies began coverage on shares of Agilent Technologies in a report on Tuesday, June 11th. They issued an “overweight” rating and a $83.00 price target on the stock. Barclays cut shares of Agilent Technologies from an “overweight” rating to an “equal weight” rating and decreased their price target for the stock from $86.00 to $78.00 in a report on Monday, July 15th. Finally, ValuEngine cut shares of Agilent Technologies from a “buy” rating to a “hold” rating in a report on Friday, July 12th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and ten have assigned a buy rating to the company. The stock currently has an average rating of “Buy” and an average price target of $83.92.
A traded down $1.37 during trading on Wednesday, reaching $66.27. The stock had a trading volume of 73,673 shares, compared to its average volume of 2,295,652. The stock has a market capitalization of $21.47 billion, a PE ratio of 23.78, a PEG ratio of 1.91 and a beta of 1.41. The company has a current ratio of 3.41, a quick ratio of 2.82 and a debt-to-equity ratio of 0.35. Agilent Technologies Inc has a one year low of $61.01 and a one year high of $82.27. The firm’s 50-day moving average is $70.99.
Agilent Technologies (NYSE:A) last released its earnings results on Tuesday, May 14th. The medical research company reported $0.71 EPS for the quarter, missing the Zacks’ consensus estimate of $0.72 by ($0.01). The firm had revenue of $1.24 billion during the quarter, compared to the consensus estimate of $1.27 billion. Agilent Technologies had a net margin of 22.25% and a return on equity of 19.71%. The firm’s revenue was up 2.7% compared to the same quarter last year. During the same period in the prior year, the company earned $0.65 EPS. On average, analysts forecast that Agilent Technologies Inc will post 3.05 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which was paid on Wednesday, July 24th. Investors of record on Tuesday, July 2nd were paid a $0.164 dividend. The ex-dividend date was Monday, July 1st. This represents a $0.66 dividend on an annualized basis and a yield of 0.99%. Agilent Technologies’s dividend payout ratio is presently 23.66%.
Agilent Technologies Profile
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.
See Also: How Do Mutual Funds Work?
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.